Trexquant Investment LP Pacific Biosciences Of California, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $1.52 Million - $3.32 Million	387,164 Added 583.43%	453,524 $2.63 Million
Q2 2022 Aug 11, 2022	BUY	$4.02 - $10.43 $266,767 - $692,134	66,360 New	66,360 $293,000
Q2 2021 Aug 12, 2021	SELL	$22.3 - $36.02 $1.02 Million - $1.64 Million	-45,633 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$26.38 - $51.15 $577,168 - $1.12 Million	21,879 Added 92.11%	45,633 $1.52 Million
Q4 2020 Feb 11, 2021	BUY	$10.5 - $28.5 $249,417 - $676,989	23,754 New	23,754 $616,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $450M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.